Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Sweden / NCT06711783
Recruiting Not applicable

Treatment of Adolescent Anorexia Nervosa

NCT06711783 · tracked via the Priya Life Science Sweden tracker
Sponsor
Region Örebro County
Phase
Not applicable
Started
2024-08-01
Last updated
2026-05-01

Condition(s) studied

Eating Disorders

Investigational drug(s) / intervention(s)

Family based therapy

Family based therapy: Family based therapy following the Maudsley model

Study summary

VISAN is a naturalistic study of family based treatment of Anorexia nervosa in adolescnet girls.

Eligibility

Sex
ALL
Min age
11 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria: * Having been diagnosed with f500 or f501 and being planned for family based therapy at the unit. Exclusion Criteria: * being subjected to care by the social welfare system

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Orebro eating disorder unit Örebro Sweden Recruiting

More Region Örebro County trials in Sweden

Physical Exercise as Treatment Post-stroke Fatigue - a Feasibilty Study. Starting soon
Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE Recruiting
Reablement in Residential Aged Care - a Randomized Controlled Trail Recruiting
A Randomized Controlled Trial With Rituximab for Psychotic Disorder in Adults Active, not recruiting
Right-sided 1-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) Versus Left-sided Intermittent Theta Burst Stimulation (iTBS) in Patients With Depression Recruiting

Other trials for the same condition

Prevention of Eating Disorders Through Optimization of Protective Factors Recruiting
A Longitudinal Study of Severe and Enduring Eating Disorders Recruiting
Evaluation of Radically Open Dialectical Behavior Therapy for Youth At Risk for Developing Severe and Enduring Eating Disorders Recruiting
We Analyse Metabolites in Dried Blood Spots From Newborns That Later in Life Developed an Eating Disorder. Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06711783 on ClinicalTrials.gov ↗ ← All trials in Sweden